Mackenzie Financial
RARE icon

Mackenzie Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History

Mackenzie Financial’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.41M Buy
+227,004
New +$5.45M ﹤0.01% 917
2025
Q3 		– Sell
-19,160
Closed -$697K – 1818
2025
Q2 		$697K Buy
19,160
+502
+3% +$18.1K ﹤0.01% 1115
2025
Q1 		$676K Buy
18,658
+2,543
+16% +$106K ﹤0.01% 1097
2024
Q4 		$678K Buy
16,115
+11,825
+276% +$587K ﹤0.01% 1051
2024
Q3 		$238K Buy
+4,290
New +$219K ﹤0.01% 1296

Other funds holding RARE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Hussman Strategic Advisors
Hussman Strategic Advisors Ellicott City, Maryland $469M AUM 10.16% 1-Year Est. Return
Crestwood Advisors Group
Crestwood Advisors Group Boston, Massachusetts $6.76B AUM 24% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Apollon Wealth Management
Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return
L. Roy Papp & Associates
L. Roy Papp & Associates Phoenix, Arizona $981M AUM 26.21% 1-Year Est. Return
Motley Fool Asset Management
Motley Fool Asset Management Alexandria, Virginia $2.64B AUM 26.58% 1-Year Est. Return

Mackenzie Financial's RARE Position: Q3 2026 in Review

Mackenzie Financial opened a new position in Ultragenyx Pharmaceutical (RARE) in Q3 2026: 227,004 shares worth $3.41M. The stake represents ﹤0.01% of the portfolio and ranks #917 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in RARE as recently as Q2 2025.

Mackenzie Financial first reported a position in RARE in Q3 2024 and has held it in 5 quarters since. 53 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • Mackenzie Financial held 227,004 shares of Ultragenyx Pharmaceutical worth $3.41M as of Q3 2026.
  • Ultragenyx Pharmaceutical was a new Mackenzie Financial position in Q3 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Mackenzie Financial's portfolio in Q3 2026, its #917 holding.
  • Mackenzie Financial first reported a position in Ultragenyx Pharmaceutical in Q3 2024 and has held it in 5 quarters since.
  • 53 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.